Unlocking the Full Potential of RNAi with LEADTM (Ligand & Enhancer Assisted Delivery)
Time: 11:30 am
day: Day 2
Details:
- Delivery is the biggest hurdle to harnessing RNAi potential as a new drug modality
- GalNAc conjugate technologies have revolutionized RNAi for liver targets. Extrahepatic delivery is the new frontier for RNA
- Sanegene’s LEAD™ technology focusing on conjugate approach effectively delivers RNAi to specific tissues or cells of therapeutic relevance
